TY  - JOUR

T1  - Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes

JO  - European Heart Journal

UR  - https://eprints.whiterose.ac.uk/id/eprint/166185

PY  - 2020/09/01

AU  - Storey RF

AU  - Gurbel PA

AU  - ten Berg J

AU  - Bernaud C

AU  - Dangas GD

AU  - Frenoux J-M

AU  - Gorog DA

AU  - Hmissi A

AU  - Kunadian V

AU  - James SK

AU  - Tanguay J-F et al

ED  - 

DO  - DOI: 10.1093/eurheartj/ehz807

PB  - Oxford University Press (OUP)

VL  - 41

IS  - 33

SP  - 3132

EP  - 3140

Y2  - 2025/11/12

ER  -